Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FL5TS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,406
Award facts
- Contract value 100% obligated
- $19,405.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Botox 200 Unit Vials. The contract represents a firm fixed-price delivery order with a ceiling value of $19,405.50 and an ultimate completion date of September 23, 2025. This award was made without a set-aside designation, allowing the vendor to compete on an unrestricted basis despite its small business status. The performance location is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026 under the SPE2DB program. The parent IDC provides the DLA with flexible procurement authority to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables serving Department of Defense healthcare facilities worldwide. As a long-standing federal contractor registered in SAM.gov since 2001, DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a demonstrated portfolio of delivering specialized pharmaceutical products including oncology treatments, vaccines, and other prescription medications to military health systems.
Quick answers
Who was awarded contract SPE2DB25FL5TS?
SPE2DB25FL5TS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FL5TS worth?
The government has obligated $19,406 on SPE2DB25FL5TS.
Is contract SPE2DB25FL5TS an order under another contract?
Yes. SPE2DB25FL5TS is a delivery order under SPE2DB22D9209, an indefinite delivery contract.
Was contract SPE2DB25FL5TS competed?
The extent of competition for SPE2DB25FL5TS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award